These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20442352)

  • 41. Developing a self-administered tool to predict adherence to antiretroviral therapy: design, method, and objectives.
    Kennedy SB
    AIDS Patient Care STDS; 2000 Jun; 14(6):309-16. PubMed ID: 10897503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Standard of care: promoting antiretroviral adherence in clinical care.
    Harman JJ; Amico KR; Johnson BT
    AIDS Care; 2005 Feb; 17(2):237-51. PubMed ID: 15763717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS.
    Proctor VE; Tesfa A; Tompkins DC
    AIDS Patient Care STDS; 1999 Sep; 13(9):535-44. PubMed ID: 10813033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapy adherence and highly active antiretroviral therapy: comparison of three sources of information.
    Vincke J; Bolton R
    AIDS Patient Care STDS; 2002 Oct; 16(10):487-95. PubMed ID: 12437860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of adherence in a cohort of Belgian HIV patients: a pilot study.
    Degroote S; Vogelaers D; Vermeir P; Mariman A; De Rick A; Van Der Gucht B; Pelgrom J; Van Wanzeele F; Verhofstede C; Vancauwenberghe J; Vandijck D
    Acta Clin Belg; 2014 Apr; 69(2):111-5. PubMed ID: 24724750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Narratives of Ugandan women adhering to HIV/AIDS medication.
    Matovu SN; La cour K; Hemmingsson H
    Occup Ther Int; 2012 Dec; 19(4):176-84. PubMed ID: 22740312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preventing antiretroviral anarchy in sub-Saharan Africa.
    Harries AD; Nyangulu DS; Hargreaves NJ; Kaluwa O; Salaniponi FM
    Lancet; 2001 Aug; 358(9279):410-4. PubMed ID: 11502341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Placebo practice trials: a tool to assess and improve adherence readiness.
    Wagner G; Iguchi M; Schneider S; Scott J; Anderson D
    HIV Clin Trials; 2002; 3(6):475-81. PubMed ID: 12501131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical and economic efficacy of HAART: a shift from inpatient medical to outpatient pharmaceutical care for HIV/AIDS patients in Northeastern Italy.
    Tramarin A; J Postma M; Gerzeli S; Campostrini S; Starace F;
    AIDS Care; 2004 Feb; 16(2):213-8. PubMed ID: 14676019
    [No Abstract]   [Full Text] [Related]  

  • 50. Adhering to antiretroviral therapies.
    Laurence J
    AIDS Patient Care STDS; 2001 Mar; 15(3):107-8. PubMed ID: 11313022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moving up from 3 by 5.
    Stoeckle M; Mchomvu R; Hatz C; Battegay M; Aris EA; Mshinda H; Tanner M
    Lancet Infect Dis; 2006 Aug; 6(8):460-1. PubMed ID: 16870522
    [No Abstract]   [Full Text] [Related]  

  • 52. Stirring the statistical pot.
    Bateman C
    S Afr Med J; 2004 Mar; 94(3):154-5. PubMed ID: 15098266
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiviral benefits for HIV-infected patients : the crucial role & multiple determinants of adherence.
    Cuzin L
    Indian J Med Res; 2008 Jan; 127(1):7-9. PubMed ID: 18316847
    [No Abstract]   [Full Text] [Related]  

  • 54. Adherence to anti-retroviral therapy and its determinants in HIV/AIDS patients: a review.
    Emamzadeh-Fard S; Fard SE; SeyedAlinaghi S; Paydary K
    Infect Disord Drug Targets; 2012 Oct; 12(5):346-56. PubMed ID: 23017163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Epidemiological studies on HIV/AIDS antiretroviral therapy in China].
    Peng ZH; Lu JF; Wang L; Wang L; Yu RB; Chen F; Wang N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Sep; 33(9):977-82. PubMed ID: 23290816
    [No Abstract]   [Full Text] [Related]  

  • 56. [Adherence to the antiretroviral therapy for HIV/AIDS].
    Colombrini MR; de I'opes MH; de Figueiredo RM
    Rev Esc Enferm USP; 2006 Dec; 40(4):576-81. PubMed ID: 17310576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Descriptive aspects of HIV/AIDS in patients aged 50 years and over followed at the Treatment Center of Bafoussam - Cameroon].
    Mbopi-Kéou FX; Djomassi LD; Monebenimp F
    Pan Afr Med J; 2012; 12():107. PubMed ID: 23133707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early antiretroviral therapy and better care retention can reduce HIV/AIDS epidemic in India.
    Nischal PM
    Natl Med J India; 2015; 28(6):314. PubMed ID: 27294472
    [No Abstract]   [Full Text] [Related]  

  • 59. Relationship of race-, sexual orientation-, and HIV-related discrimination with adherence to HIV treatment: a pilot study.
    Boarts JM; Bogart LM; Tabak MA; Armelie AP; Delahanty DL
    J Behav Med; 2008 Oct; 31(5):445-51. PubMed ID: 18726151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maximizing antiretroviral therapy in developing countries: the dual challenge of efficiency and quality.
    Murray CJ
    JAMA; 2015 Jan; 313(4):359-60. PubMed ID: 25436833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.